Dashboard
Manage Tickers

AMGN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fake-ozempic-targets-weight-loss-market-forged-batches-an-international-concern
Fake Ozempic Targets Weight-Loss Market: F...
09/05/2024 17:17:20

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation...

Core News & Articles
MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters 

amgen-ceo-says-look-forward-to-obesity-drug-trial-data-showing-what-we-can-achieve-in-patients-that-are-obese--at-risk-of-heart-renal-liver-disease
Amgen CEO Says Look Forward To Obesity Dru...
09/04/2024 13:51:36

- Morgan Stanley Conf

despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs
Despite Medicare Negotiations, Americans M...
09/03/2024 19:12:09

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

amgn---analyzing-amgens-short-interest
(AMGN) - Analyzing Amgen's Short Interest
09/03/2024 18:15:23

amgen-unusual-options-activity-for-august-29
Amgen Unusual Options Activity For August 29
08/29/2024 19:48:54

intuit-amgen-and-sprott-uranium-miners-etf-cnbcs-final-trades
Intuit, Amgen And Sprott Uranium Miners ET...
08/29/2024 12:48:20

Jason Snipe of Odyssey Capital Advisors likes Intuit Inc., after the company beat on the top and bottom lines, but missed on gu...

Core News & Articles
CNBC Halftime Report Final Trades: Intuit,...
08/28/2024 17:01:25

moodys-revises-amgens-outlook-to-stable-from-negative
Moody's Revises Amgen's Outlook To Stable ...
08/22/2024 19:47:19

- Reuters Citing Moody's Ratings

amgen-announces-availability-of-otezla-in-the-us-for-pediatric-use
Amgen Announces Availability Of Otezla In ...
08/20/2024 13:03:31

us-stocks-may-take-a-breather-after-sp-500s-impressive-8-session-winning-streak-strategist-says-market-will-hit-fresh-highs-in-next-4-weeks-but-warns-investors-of-potential-risks
US Stocks May Take A Breather After S&P 50...
08/20/2024 10:47:18

The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the rec...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
08/15/2024 17:35:23

smart-money-is-betting-big-in-amgn-options
Smart Money Is Betting Big In AMGN Options
08/12/2024 16:45:46

amgen-options-trading-a-deep-dive-into-market-sentiment
Amgen Options Trading: A Deep Dive into Ma...
08/08/2024 14:47:03

td-cowen-maintains-buy-on-amgen-raises-price-target-to-381
TD Cowen Maintains Buy on Amgen, Raises Pr...
08/07/2024 21:11:46

TD Cowen analyst Yaron Weber maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $360 to $381.

amgens-mixed-q2-results-highlight-obesity-drug-potential-analysts-focus-shifts-to-upcoming-clinical-readouts
Amgen's Mixed Q2 Results Highlight Obesity...
08/07/2024 18:01:22

Amgen posted mixed Q2 results. Analysts highlight upcoming clinical readouts in obesity and inflammatory disease as crucial. De...

oppenheimer-maintains-outperform-on-amgen-maintains-380-price-target
Oppenheimer Maintains Outperform on Amgen,...
08/07/2024 17:55:04

Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and maintains $380 price target.

deutsche-bank-reiterates-hold-on-amgen-lowers-price-target-to-305
Deutsche Bank Reiterates Hold on Amgen, Lo...
08/07/2024 17:30:13

Deutsche Bank analyst James Shin reiterates Amgen (NASDAQ:AMGN) with a Hold and lowers the price target from $310 to $305.

b-of-a-securities-maintains-neutral-on-amgen-raises-price-target-to-330
B of A Securities Maintains Neutral on Amg...
08/07/2024 17:08:40

B of A Securities analyst Geoff Meacham maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $325 t...

wall-street-poised-for-second-day-of-gains-while-bank-of-japan-makes-reassurances-dollar-strengthens-against-yen-crude-prices-surge-whats-driving-markets-wednesday
Wall Street Poised For Second Day Of Gains...
08/07/2024 16:46:55

The U.S.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION